Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lenvatinib

Various toxicities: 2 case reports

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Sukumar JS, et al. Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer. International Journal of Endocrine Oncology 6: 0007, No. 4, 7 Nov 2019. Available from: URL: http://doi.org/10.2217/ije-2019-0007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Lenvatinib. Reactions Weekly 1791, 159 (2020). https://doi.org/10.1007/s40278-020-75004-x

    Download citation